This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Canadians Living With Osteoporosis Have Access To A New Treatment Option

Provinical Governments List Aclasta on Public Drug Plans

TORONTO, Nov. 22, 2012 /CNW/ - Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta ( zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment options.

"With the announcement of Aclasta available on public and private drug plans, individuals living  with osteoporosis in these provinces will have access to another option for the treatment of this debilitating disease," said Dr. Famida Jiwa, president and CEO, Osteoporosis Canada. "While Osteoporosis Canada applauds the many provincial governments for increasing access, the organization continues to work with other provinces and territories to ensure that all patients with osteoporosis have options and access to the medications they need."

The Criteria for Aclasta

All Osteoporosis patients in Ontario, Saskatchewan, British Columbia and New Brunswick covered by their provincial drug plan or by private drug plans now have access to Aclasta, a new treatment for those with osteoporosis at high risk for fracture.

Aclasta is recommended for
  • The treatment of osteoporosis in postmenopausal women, as a once-yearly intravenous infusion, to reduce the incidence of hip, vertebral and non-vertebral fractures
  • The treatment to increase bone mineral density in men with osteoporosis, as a once-yearly intravenous infusion
  • The treatment and prevention of glucocorticoid-induced osteoporosis, to increase bone mineral density, as a once-yearly intravenous infusion
  • The prevention of postmenopausal osteoporosis in women with osteopenia as a single intravenous infusion
  • The treatment of Paget's disease of the bone in men and women, as a single-dose intravenous infusion

Special Authority criteria

For women with postmenopausal osteoporosis, for whom oral bisphosphonates are contraindicated due to abnormalities of the esophagus (e.g. ., stricture or achalasia).

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs